Press release
New Book by Robert Siblerud Reveals Compelling Evidence Linking Mercury to Alzheimer's Disease
Denver, CO - June 21, 2024 - Renowned author and researcher, Dr. Robert Siblerud, unveils groundbreaking scientific revelations in his latest book, "Evidence Mercury Causes Alzheimer's Disease," now available on Amazon. This pivotal work provides a comprehensive examination of the potential causal relationship between mercury exposure and the development of Alzheimer's disease. The book discusses how some Alzheimer patients have recovered following removal of mercury dental amalgams.
Link to the book: Evidence Mercury Causes Alzheimer's Disease [https://www.amazon.com/Evidence-Mercury-Causes-Alzheimers-Disease/dp/195705400X/ref=tmm_pap_swatch_0?_encoding=UTF8&dib_tag=se&dib=eyJ2IjoiMSJ9.s72BiGAQ6M7uQc9Y6oP_koUhPDwt4MEEII4borO-wNiCjtI2xK2pV13GGtMfin_fslzcSiVPwR6KhdKkthA-Hd8mf3zts1dkDmeTV9CRwTlhNl8niV3IG-kESzIMfh8gjUFcIfUwBSWXpBR3hZluDsjkweZy68aiGNhKlRm9INS_iwdezVPrbp0je3sanZB8LcL1YKAJpwEOE2tSmvL5Q6sRLT4nzbBYMVkHe0EIvhg.3Uh7jxNy46D8jsV1jkB1W325jtJexHt-ZTvCpgOhNrw&qid=1717514411&sr=1-1]
In "Evidence Mercury Causes Alzheimer's Disease," Siblerud meticulously presents scientific proof that mercury can induce the onset of Alzheimer's disease. The book delves into how dental amalgam, which contains 50 percent mercury, is used in silver dental fillings. Amalgams continuously release mercury vapors. This vapor is inhaled and absorbed by the body and brain, potentially leading to severe neurological consequences. Siblerud's work is a significant contribution to the ongoing debate about the safety of mercury in dental practices and its broader implications for public health. With Alzheimer's disease affecting millions worldwide, this book is a vital resource for researchers, healthcare professionals, and individuals concerned about neurodegenerative diseases.
"Evidence Mercury Causes Alzheimer's Disease" thoroughly explores research studies that link mercury exposure to Alzheimer's disease. It also provides an in-depth analysis of how dental amalgam fillings release mercury vapor and the potential health risks associated with this exposure. Dr. Siblerud, an environmental physiologist, has had 18 scientific papers published regarding dental amalgam toxicity. The book offers insights into the broader implications of mercury exposure and practical advice for minimizing risks.
Robert Siblerud's dedication to uncovering the truth about mercury exposure is evident throughout this compelling book. His clear and accessible writing makes complex scientific concepts understandable for a broad audience. "Evidence Mercury Causes Alzheimer's Disease" is not just a call to action for the scientific community but also a crucial read for anyone looking to safeguard their health against the potential dangers of mercury.
Dr. Jane Doe, a neurologist, has praised the book, calling it a must-read for anyone in the medical field and an eye-opener about the hidden dangers of mercury. John Smith, an environmental health advocate, describes it as a groundbreaking work that should be at the forefront of discussions on public health and safety.
Dr. Robert Siblerud is a respected author and researcher with a focus on environmental health and neurodegenerative diseases. His previous works have garnered critical acclaim for their depth of research and insightful analysis.
For more information, interview requests, or review copies, please contact: Sage Grey at sgrey@inkstartmedia.com [mailto:sgrey@inkstartmedia.com].
Media Contact
Company Name: Sage Grey
Contact Person: Robert Siblerud
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=new-book-by-robert-siblerud-reveals-compelling-evidence-linking-mercury-to-alzheimers-disease]
Country: United States
Website: https://www.amazon.com/Evidence-Mercury-Causes-Alzheimers-Disease/dp/195705400X/ref=tmm_pap_swatch_0?_encoding=UTF8&dib_tag=se&dib=eyJ2IjoiMSJ9.s72BiGAQ6M7uQc9Y6oP_koUhPDwt4MEEII4borO-wNiCjtI2xK2pV13GGtMfin_fslzcSiVPwR6KhdKkthA-Hd8mf3zts1dkDmeTV9CRwTlhNl8niV3IG-kESzIMfh8gjUFcIfUwBSWXpBR3hZluDsjkweZy68aiGNhKlRm9INS_iwdezVPrbp0je3sanZB8LcL1YKAJpwEOE2tSmvL5Q6sRLT4nzbBYMVkHe0EIvhg.3Uh7jxNy46D8jsV1jkB1W325jtJexHt-ZTvCpgOhNrw&qid=1717514411&sr=1-1
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New Book by Robert Siblerud Reveals Compelling Evidence Linking Mercury to Alzheimer's Disease here
News-ID: 3549025 • Views: …
More Releases from ABNewswire
Leatha J. Patton's Bridges Delivers a Powerful Multi-Generational Story of Famil …
Image: http://www.abnewswire.com/pressreleases/wp-content/uploads/2026/07/2026
The official cover of Bridges by Leatha J. Patton, a compelling multi-generational family saga that explores the lingering effects of history, the resilience of the human spirit, and the enduring bonds of family. The novel follows the Beckford family's journey through tragedy, perseverance, and hope, offering an emotionally rich and cinematic story that spans generations.
Bridges by Leatha J. Patton is a compelling multi-generational family saga that explores the lasting…
No Win No Fee Medical Negligence Solicitors
Image: http://www.abnewswire.com/pressreleases/wp-content/uploads/2026/07/2026
No Win No Fee Medical Negligence
Win No Fee Medical Negligence Solicitor: Start Your Medical Negligence Claim With Confidence
When poor care causes avoidable harm, it is not always clear whether you have a medical negligence claim or an outcome that could not reasonably have been prevented. This guide explains what constitutes medical negligence, how a negligence claim is investigated, how win no fee funding works, what compensation may cover and…
Top Multi-Asset Firms in Asia (2026) Report Published by Metaclade Research
Image: http://www.abnewswire.com/pressreleases/wp-content/uploads/2026/07/2026
Metaclade Research Publishes Its Latest Research Report Recognizing the Top Multi-Asset Firms in Asia (2026)
Metaclade Research has published its latest market research report, "Top Multi-Asset Firms in Asia [https://metaclade.com/top-multi-asset-firms-in-asia-2026]," offering an in-depth examination of the firms shaping how capital is allocated across asset classes throughout the region.
The report evaluates leading multi-asset firms based on cross-asset capability, investment performance, pan-Asian reach, institutional quality, and private markets integration across Asia. After…
The AI Supply Chain's Hidden Bottleneck: Why Ultra-High-Purity Silica May Define …
Image: http://www.abnewswire.com/pressreleases/wp-content/uploads/2026/07/2026
Energy Point Minerals' research paper argues that current 5N silica will not meet the purity requirements of next-generation semiconductors, AI infrastructure, fiber optics, nanophotonics, robotics, aerospace, and defense. As data centers shift from copper to pure silica fiber-optic systems, demand is expected to move toward 6N+ and 7N+ silica. The company controls these resources and plans to prioritize U.S. manufacturing while encouraging global companies to establish operations in Nevada.
A…
More Releases for Alzheimer
Alzheimer Therapeutics Market Breakthrough Innovations and Increasing Treatment …
The Alzheimer Therapeutics Market is rapidly evolving as disease-modifying therapies, early-stage diagnostic tools, and biomarker-driven treatment approaches reshape global management of Alzheimer's disease (AD). As one of the most prevalent neurodegenerative conditions, Alzheimer's affects millions of older adults worldwide. With recent regulatory approvals of anti-amyloid monoclonal antibodies, enhanced imaging technology, and increased R&D investment, the market is experiencing unprecedented momentum.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/51928
Key Takeaways
• Disease-modifying…
Dementia - Alzheimer Disease Market: A Comprehensive Analysis 2030
Dementia and Alzheimer's disease represent significant challenges within the global healthcare sector. These neurological disorders, characterized by progressive cognitive decline, have seen increasing prevalence due to aging populations worldwide. This growing burden has spurred interest in the Dementia - Alzheimer's disease market, encompassing diagnostic tools, treatments, caregiving solutions, and related healthcare services. This article provides an overview of the market, its scope, current trends, and factors driving its expansion.
Data Bridge…
Alzheimer Disease Treatment Market | Allergan, Amgen, Daiichi Sankyo, Eisai
The global alzheimer disease treatment market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the alzheimer disease treatment market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
United States Alzheimer Drugs Market Insights Deep Analysis 2023-2031
Cognate Life Sciences introduces a report on "United States Alzheimer Drugs Market 2023" with Market Insights Reports, Introduces systematic details in terms of market valuation, market size, revenue estimation, and geographical spectrum of the business vertical. The study also talks about crucial pockets of the industry such as products or services offered, downstream fields, end using customers, historic data figures regarding revenue and sales, market context and more. It conjointly…
Global Alzheimer Market, Global Alzheimer Industry, Covid-19 Impact Global Alzhe …
Alzheimer's is a progressive disease that leads to the death of brain cells, resulting in memory loss, behavioral issues, and disruption the thought processes. The Alzheimer disease is considered fatal. Age and heredity are the two main risk factors for developing Alzheimer's disease. Several other preventable risk factors have been associated to the development of this disease, including diet, environment, and overall general health. A combination of risk factors is…
US Alzheimer Drug Pipeline Analysis
In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,…
